Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program

CI Bloom, C Cabrera, S Arnetorp, K Coulton, C Nan… - Advances in …, 2020 - Springer
Introduction Patients with asthma typically increase short-acting β 2-agonists (SABA) use
with worsening symptoms. Excessive SABA use may lead to a higher risk of adverse …

Balancing the needs of the many and the few: where next for adult asthma guidelines?

DE Shaw, LG Heaney, M Thomas… - The Lancet …, 2021 - thelancet.com
Asthma differs from many other chronic conditions in that most key management decisions
are made in non-specialist settings, such as general practitioner surgeries and accident and …

Trends in hospital admissions and prescribing due to chronic obstructive pulmonary disease and asthma in England and Wales between 1999 and 2020: an …

H Alwafi, AY Naser, DS Ashoor, AM Aldhahir… - BMC Pulmonary …, 2023 - Springer
Objective To investigate the trends in hospital admissions and medication prescriptions
related to asthma and chronic obstructive pulmonary disease (COPD) in England and …

The NHS deserves better use of hospital medicines data

B Goldacre, B MacKenna - bmj, 2020 - bmj.com
The NHS deserves better use of hospital medicines data Page 1 The NHS deserves better use
of hospital medicines data Ben GoldacreandBrian MacKennaargue that hospital medicines …

Asthma prescribing trends, inhaler adherence and outcomes: a Real-World Data analysis of a multi-ethnic Asian Asthma population

MR Toh, GXZ Ng, I Goel, SW Lam, JT Wu… - NPJ Primary Care …, 2024 - nature.com
Inhaled corticosteroid (ICS) is the mainstay therapy for asthma, but general adherence is
low. There is a paucity of real-world inhaler prescribing and adherence data from Asia and …

Evaluating the relationship between the type of rescue medication and the adequacy of asthma maintenance therapy

EV Ponte, DG da Rocha, RM Guinossi, L Bertoche… - Respiratory …, 2023 - Elsevier
Introduction Current guidelines incorporate the option of a rapid onset bronchodilator (ROB)
plus an inhaled corticosteroid (ICS) for the relief of asthma symptoms, but there is doubt …

Anti-inflammatory reliever therapy for asthma

B Lipworth, R Chan, CRW Kuo - Annals of Allergy, Asthma & …, 2020 - annallergy.org
The potential concern with using a fixed-dose inhaled corticosteroid (ICS) or an ICS with a
long-acting b-agonist (LABA) is the possibility that patients will stop using their controller …

A new pathway to airway relaxation: targeting the “other” cyclase in asthma

M Lam, JE Bourke - American Journal of Respiratory Cell and …, 2020 - atsjournals.org
Significant concerns have recently been raised about sole therapy with inhaled short-acting
b2-adrenoceptor agonists (SABAs) in poorly controlled asthma in the absence of …

Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care

B MacKenna, HJ Curtis, AJ Walker, S Bacon… - British Journal of …, 2020 - bjgp.org
Background Electronic health record (EHR) systems are used by clinicians to record
patients' medical information, and support clinical activities such as prescribing. In England …

It is time to end our love affair with short-acting β2-agonists in asthma

MG Crooks, S Faruqi - ERJ Open Research, 2022 - Eur Respiratory Soc
It is time to end our love affair with short-acting β2-agonists in asthma | European
Respiratory Society Skip to main content Main menu Home Current issue Early View …